Factors associated with improvement in symptoms and quality of life for first-line EGFR-tyrosine kinase inhibitor treatment in patients with <i>EGFR</i>-mutated non-small-cell lung cancer

Yu-Feng WeiWen-Tsung HuangTu-Chen LiuJiunn-Min ShiehChih-Feng ChianMing-Fang WuChih-Cheng ChangChing-Hsiung LinJen-Chung KoChia-Mo LinTe-Chun Hsia2026-01-292026-01-29201910.7150/jca.30507https://scholars.csmu.edu.tw/handle/123456789/3849[SDGs]SDG3Factors associated with improvement in symptoms and quality of life for first-line EGFR-tyrosine kinase inhibitor treatment in patients with <i>EGFR</i>-mutated non-small-cell lung cancer - A multicenter prospective SMILE studyjournal-article